Ibrutinib-triggered matriptase maintains extracellular CD19 and limits antigen escape in B-cell malignancy
31 August 2026 at 08:00
Cell Death Discovery, Published online: 31 August 2026; doi:10.1038/s41420-026-03306-5
Ibrutinib-triggered matriptase maintains extracellular CD19 and limits antigen escape in B-cell malignancy